Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1838]

PARP inhibitors for metastatic breast cancer

Prof Banu Arun - MD Anderson Cancer Center, Houston, USA

PARP inhibitors for metastatic breast cancer ( Prof Banu Arun - MD Anderson Cancer Center, Houston, USA )

Breast cancer care in low-middle income settings

Prof Benjamin Anderson - Fred Hutchinson Cancer Center, Seattle, USA

Breast cancer care in low-middle income settings ( Prof Benjamin Anderson - Fred Hutchinson Cancer Center, Seattle, USA )

Steps for patients who do not receive complete response after neoadjuvant...

Prof Edith Perez - Mayo Clinic Cancer Centre, Rochester, USA

Steps for patients who do not receive complete response after neoadjuvant therapy ( Prof Edith Perez - Mayo Clinic Cancer Centre, Rochester, USA )

BRCA testing in breast and ovarian cancer

Prof Frederique Penault-Llorca - Jean Perrin Center, Clermont-Ferrand, France

BRCA testing in breast and ovarian cancer ( Prof Frederique Penault-Llorca - Jean Perrin Center, Clermont-Ferrand, France )

Advances in breast cancer treatment over the last 20 years

Dr Philip Poortmans - Institut Curie, Paris, France

Advances in breast cancer treatment over the last 20 years ( Dr Philip Poortmans - Institut Curie, Paris, France )

An overview of recent metastatic HER2 breast cancer trials

Prof Sandra Swain - Georgetown University Medical Centre, Washington, USA

An overview of recent metastatic HER2 breast cancer trials ( Prof Sandra Swain - Georgetown University Medical Centre, Washington, USA )

Modern mammography-guided breast interventions

Dr Rodrigo Alcantara - Hospital del Mar, Barcelona, Spain

Modern mammography-guided breast interventions ( Dr Rodrigo Alcantara - Hospital del Mar, Barcelona, Spain )

The added value of contrast-enhanced spectral mammography for the assessment of...

Dr Rodrigo Alcantara - Hospital del Mar, Barcelona, Spain

The added value of contrast-enhanced spectral mammography for the assessment of symptomatic breast cancer patients ( Dr Rodrigo Alcantara - Hospital del Mar, Barcelona, Spain )

Chemotherapy in patients with luminal breast cancer and an intermediate risk...

Prof Joseph Gligorov - Paris-Sorbonne University, Paris, France

Chemotherapy in patients with luminal breast cancer and an intermediate risk recurrence score ( Prof Joseph Gligorov - Paris-Sorbonne University, Paris, France )

Preoperative management of operable cT3 cN1 luminal breast cancer: Upfront...

Prof Joseph Gligorov - Paris-Sorbonne University, Paris, France

Preoperative management of operable cT3 cN1 luminal breast cancer: Upfront neoadjuvant chemotherapy ( Prof Joseph Gligorov - Paris-Sorbonne University, Paris, France )

Dual HER2 blockade in patients with HER2-positive breast cancer after pCR

Prof Joseph Gligorov - Paris-Sorbonne University, Paris, France

Dual HER2 blockade in patients with HER2-positive breast cancer after pCR ( Prof Joseph Gligorov - Paris-Sorbonne University, Paris, France )

Triple-positive breast cancer: Systemic management strategies

Prof Pierre Conte - University of Padova, Padova, Italy

Triple-positive breast cancer: Systemic management strategies ( Prof Pierre Conte - University of Padova, Padova, Italy )

More from ecancer